Search

everythinglearnresearchcommunity

for

Search:↓

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

A three-year-old girl survived a rare serious infection caused by BCG vaccination, which improved after treatment with a leprosy drug.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Two men experienced hair regrowth while being treated with immune globulin for other health issues, but there were also side effects.

Baricitinib maintains significant hair regrowth in severe alopecia areata over three years.

Dupilumab helped improve skin and prevent new lesions in a child with a rare immune disorder and severe eczema.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Baricitinib was effective in treating alopecia areata in two major trials.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Cyclosporine effectively treated a woman's stubborn skin condition.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Janus kinase inhibitors may effectively treat resistant scalp conditions like folliculitis decalvans and dissecting cellulitis.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Immunological treatment improved both neuropathy and alopecia.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

C4BPA protein may link acne severity and insulin resistance.